Bontac Honored as a National-Level 'Little Giant' Enterprise
On October 20, 2025, the Shenzhen SME Service Bureau announced the list of the seventh batch of "Little Giant" enterprises and the 2025 re-evaluated enterprises.
Bontac, with its outstanding comprehensive strength, was successfully selected as one of the seventh batch of national-level "Little Giant" enterprises.
This prestigious recognition shines like a bright beacon, illuminating Bontac path forward in the biotechnology industry.
According to the Interim Measures for the Gradient Cultivation and Management of High-Quality SMEs, "Little Giant" enterprises must meet comprehensive standards across six dimensions: specialization, refinement, uniqueness, innovation, industrial chain, and product quality.
As leaders among specialized and innovative SMEs, these enterprises focus on core areas of industrial foundations and key links in the industrial chain.
They possess strong innovation capacity, core technologies, and market competitiveness—serving as role models for high-quality SMEs and representing the highest and most authoritative level of recognition in enterprise evaluation.
After being recognized in 2021 as a Shenzhen-level "Specialized and Innovative SME," Bontac has now received national-level recognition, fully reflecting the government’s high appraisal of the company’s product strength, technological capabilities, and innovation achievements.
This honor will further enhance the company’s brand influence and market competitiveness.
As a pioneer in the NMN industry, Bontac developed the world’s first full-enzyme catalytic technology and has become a leader in the coenzyme product segment.
Its products span six major categories: coenzymes, natural products, sugar substitutes, cosmetic ingredients, dietary supplements, and pharmaceutical intermediates.
These are widely applied in nutrition and health, biomedicine, medical aesthetics, and green agriculture.
The company has always adhered to independent innovation, with over 200 domestic and international patent applications,
multiple key provincial and municipal technology projects, and the establishment of the first and only provincial Coenzyme Engineering Technology Research Center in Guangdong.
Standing at a new starting point, Bontac will take this national recognition as a new driving force to continue leveraging its strengths in green, low-carbon, and high-value-added biotechnological industrialization.
The company will work with domestic and international research institutes and upstream and downstream partners to build an industrial ecosystem,
continuously leading the synthetic biology industry and contributing to a healthier and better life for humanity.
Bontac, with its outstanding comprehensive strength, was successfully selected as one of the seventh batch of national-level "Little Giant" enterprises.
This prestigious recognition shines like a bright beacon, illuminating Bontac path forward in the biotechnology industry.
According to the Interim Measures for the Gradient Cultivation and Management of High-Quality SMEs, "Little Giant" enterprises must meet comprehensive standards across six dimensions: specialization, refinement, uniqueness, innovation, industrial chain, and product quality.
As leaders among specialized and innovative SMEs, these enterprises focus on core areas of industrial foundations and key links in the industrial chain.
They possess strong innovation capacity, core technologies, and market competitiveness—serving as role models for high-quality SMEs and representing the highest and most authoritative level of recognition in enterprise evaluation.
After being recognized in 2021 as a Shenzhen-level "Specialized and Innovative SME," Bontac has now received national-level recognition, fully reflecting the government’s high appraisal of the company’s product strength, technological capabilities, and innovation achievements.
This honor will further enhance the company’s brand influence and market competitiveness.
As a pioneer in the NMN industry, Bontac developed the world’s first full-enzyme catalytic technology and has become a leader in the coenzyme product segment.
Its products span six major categories: coenzymes, natural products, sugar substitutes, cosmetic ingredients, dietary supplements, and pharmaceutical intermediates.
These are widely applied in nutrition and health, biomedicine, medical aesthetics, and green agriculture.
The company has always adhered to independent innovation, with over 200 domestic and international patent applications,
multiple key provincial and municipal technology projects, and the establishment of the first and only provincial Coenzyme Engineering Technology Research Center in Guangdong.
Standing at a new starting point, Bontac will take this national recognition as a new driving force to continue leveraging its strengths in green, low-carbon, and high-value-added biotechnological industrialization.
The company will work with domestic and international research institutes and upstream and downstream partners to build an industrial ecosystem,
continuously leading the synthetic biology industry and contributing to a healthier and better life for humanity.
.jpg?imageView2/1/w/360/h/200)
